1Gertz MA. The classification and typing of amyloid deposits. Am JClin Pathol, 2004, 121: 787-789.
2Merlini G. Systemic amyloidosis: are we moving ahead? Neth J Med, 2004, 62: 104-105.
3Buxbaum JN. The systemic amyloidoses. Curr Opin Rheurnatol,2004, 16: 67-75.
4Merlini G, Westermark P. The systemic amyloidoses: clearer under standing of the molecular mechanisms offers hope for more effective therapies. J Intern Med, 2004, 255: 159-178.
5Giasson BI, Lee VM, Trojanowski JQ. Interactions of amyloidogenic proteins. Neuromolecular Med, 2003, 4: 49-58.
6Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med, 2003, 349: 583-596.
7Blumenthal HT. Amyloidosis: a universal disease of aging? J Gerontol A Biol Sci Med Sci, 2004, 59: 361-369.
8Magy N.AA Amyloidosis: recent knowledges on pathophysiology. Rev Med Interne, 2004, 25: 129-134.
9Steciuk A, Dompmartin A, Troussard X, et al. Cutaneous amyloidosis and possible association with systemic amyloidosis. Int J Dermatol, 2002, 41: 127-134.
10Wang WJ. Clinical features of cutaneous amyloidoses. Clin Dermatol, 1990, 8: 13-19.
